Clinical Chemistry, Malmö
11 – 20 of 1344
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients : Insights From DEFINE-HF
- Contribution to journal › Article
-
Mark
Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies
- Contribution to journal › Article
-
Mark
Machine Learning-enhanced X-ray-based Radiomics in the Identification of Post-COVID Patients
- Contribution to journal › Article
-
Mark
Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves prediction across ancestry groups
- Contribution to journal › Article
-
Mark
Contact activation of coagulation in newly inserted indwelling catheters
- Contribution to journal › Article
-
Mark
Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes
- Contribution to journal › Article
-
Mark
TMEM160 Promotes Tumor Growth in Lung Adenocarcinoma and Cervical Adenocarcinoma Cell Lines
- Contribution to journal › Article
-
Mark
High circulating activin A plasma levels are associated with tumour stage and poor survival in treatment-naive lung squamous cell cancer patients
- Contribution to journal › Article
-
Mark
Re: Early Prostate Cancer Deaths Among Men with Higher vs Lower Genetic Risk
- Contribution to journal › Debate/Note/Editorial
-
Mark
Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma
- Contribution to journal › Article
